Covalon Technologies ( (TSE:COV) ) has issued an update.
Covalon Technologies Ltd. has announced its annual meeting of shareholders, scheduled for March 19, 2025, to be held virtually. The meeting will feature a presentation by the newly appointed CEO, Brent Ashton, followed by a Q&A session, allowing shareholders to engage and vote online, reflecting the company’s commitment to transparent and accessible governance.
More about Covalon Technologies
Covalon Technologies Ltd. is an advanced medical technologies company based in Mississauga, Ontario, Canada. The company is focused on developing innovative medical products and solutions, primarily targeting the healthcare industry.
YTD Price Performance: -23.64%
Average Trading Volume: 41,242
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$65.53M
See more data about COV stock on TipRanks’ Stock Analysis page.